Trial Profile
A Phase I Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Carboplatin
- Indications Solid tumours
- Focus Adverse reactions
- 12 May 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2014 New trial record